Skip to main content
Lir Life Sciences Corp. logo

Lir Life Sciences Corp. — Investor Relations & Filings

Ticker · SKNY LEI · 894500GZQCXFABJI4496 CSE Manufacturing
Open in API
Filings indexed 141 across all filing types
Latest filing 2025-04-02 Regulatory Filings
Country CA Canada
Listing CSE SKNY

About Lir Life Sciences Corp.

https://lirlife.com

Lir Life Sciences Corp. is a biopharmaceutical company specializing in the development of next-generation therapies for obesity and metabolic disorders. The company's core focus is advancing treatment accessibility through innovative drug-delivery approaches, specifically developing transdermal and alternative GLP-1 solutions. These therapies are designed to be scalable, affordable, and accessible globally, aiming to reduce reliance on traditional injections. Lir Life Sciences targets regions with rising obesity rates and limited access to existing GLP-1 treatments, addressing a significant unmet need in the rapidly growing global market.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 “Venture Issuer Basic Certificate,” which is a CEO certification of interim financial filings under Canadian NI 52-109. It does not include the interim financial statements or MD&A themselves, but is a regulatory certificate accompanying those filings. It is not the full interim report (IR), nor a simple announcement of a report (RPA). Therefore, it falls into the general Regulatory Filings category (RNS).
2025-04-02 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 “Certification of Interim Filings” by the CFO confirming review and fair presentation of the interim financial report and MD&A for the period ended January 31, 2025. It is a standalone regulatory certificate, not the actual interim report itself, nor an announcement of a report’s publication, nor any other specific category. Therefore it falls under the fallback “Regulatory Filings” category (RNS).
2025-04-02 English
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations for the three and nine months ended January 31, 2025,” contains detailed narrative commentary on financial performance, forward-looking statements, liquidity, capital resources, and operating results. This aligns perfectly with our definition of a Management Report (MD&A) rather than a full quarterly report, earnings release, or announcement. Therefore, it should be classified under Management Reports (MDA).
2025-04-02 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Condensed Consolidated Interim Financial Statements' for Blackbird Critical Metals Corp. It includes comprehensive financial statements (Statement of Financial Position, Statement of Loss and Comprehensive Loss, Statement of Changes in Equity, and Statement of Cash Flows) for the three and nine months ended January 31, 2025. It contains detailed notes to the financial statements and is prepared in accordance with IAS 34. This fits the definition of an Interim/Quarterly Report (IR). 9M 2025
2025-04-02 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 1% confidence The document is a Canadian National Instrument 45-106 Form 45-106F1 “Report of Exempt Distribution,” a detailed regulatory filing required to disclose securities sold under prospectus exemptions. It does not match any narrow categories such as AGM materials, earnings releases, proxy statements, or share buybacks; nor is it a simple announcement of a financing. It is not the company’s annual or quarterly report, nor a press release on a new share issue, but rather a mandatory compliance filing. Therefore it is best classified under the general Regulatory Filings category (RNS).
2025-02-07 English
Material change report - English.pdf
Share Issue/Capital Change Classification · 1% confidence The document is a mandatory Canadian Form 51-102F3 Material Change Report announcing completion of a debt settlement through issuance of common shares and share issuance under an option agreement. This constitutes an announcement of new share issuances/capital changes rather than a full financial report or funding call. It best fits the “Share Issue/Capital Change” category (SHA).
2025-01-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.